About Us
SingViva, an Insurance Exchange was incorporated in 2021 and the founding team believe in delivering better solutions for both consumers and distribution partners.
We have built a next generation Risk Score to predict major health risks faced by individuals and give end consumers better and faster access to insurance. Created from over 10 years of academic research and real world experience our Risk Score empowers people to recognise their key health risks.
Our Vision
Our Team
Joseph C Koh
Co-Founder, CEO
Joseph is a serial entrepreneur, who believes in building businesses and supporting community concurrently. Previously COO of a now SGX-listed fintech company, Read More
Joseph current sits as a board member of a Singapore regulated charity organization with focus in fund-raising for humanitarian efforts and disasters relief. He has been active in social works since his mid-20s. Joseph holds a Bachelor of Business (Melbourne, Australia) and was a commissioned army officer in the Singapore Armed Forces.
Kenny Thing
Board of Advisory
Kenny is an experienced professional having served more than 20 years in the life insurance and wealth management industry. His last role being CEO of a commercial Read More
During his early years, he was leading the growth of one of the largest Bancassurance partnership and Investment Platform based in Singapore and has worked as an Investment banker, providing investment and structured product solutions to Private & Retail banks in Asean. Currently, Kenny served as Advisor for Medical Group/Educational Group/Financial Advisory firm and Insurtech firm based in Malaysia/Singapore. He holds a Master Degree in Finance and attended the Executive Education at Richard Ivey, Western Ontario and INSEAD, France.
Dr. Ron Tan
PhD
Dr Ron Tan is a well-known researcher in academic research and innovations in medtech and digital healthcare space, particularly in area of predictive analytics, Read More
Currently founder of Pathomics Health Group, Dr Ron has grown the group leaps and bounds, becoming a leading genomic data centre and cancer diagnostic lab in the region, while forming strategic collaborative partnerships with many hospitals, universities, pharmaceutical companies and research institutes. Dr Tan graduated with his PhD in Biomedical Science from National University of Singapore. His research interests include development of diagnostics for infectious diseases and cancers, as well as studies on key biomarkers discovery using proteomics and genomics. To date, Dr Tan has published more than 35 international peer reviewed journals, 1 book chapter, 2 international patents and 3 know-hows. He has won many awards, notably the Best Innovative Award for Public Service in 2004, Excellence in R&D Award in 2012.
Anthony Koh
Board of Advisory
Koh is a visionary, thought leader and serial technopreneur, with more than 20 years of running businesses in emerging technologies, especially in the field of Read More